Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin in pediatric patients with peritoneal mesothelioma: a single institution experience and long term follow up
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 38 (1) , 326-331
Abstract
Malignant peritoneal mesothelioma (MPM) is a lethal cancer, with approximately 2% of diagnoses occurring in patients less than 40 years of age. The purpose of this study is to report the only long-...Keywords
This publication has 16 references indexed in Scilit:
- Distinctive clinical characteristics of malignant mesothelioma in young patientsOncotarget, 2015
- Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesotheliomaSurgery, 2013
- Clinical, histologic, and genetic features of mesothelioma in a 7‐Year‐old childPediatric Blood & Cancer, 2012
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional ExperienceJournal of Clinical Oncology, 2009
- Treatment of peritoneal mesothelioma in pediatric patientsPediatric Blood & Cancer, 2008
- Comprehensive management of diffuse malignant peritoneal mesotheliomaEuropean Journal of Surgical Oncology, 2006
- Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy: Results of a Prospective StudyAnnals of Surgical Oncology, 2006
- Analysis of Factors Associated With Outcome in Patients With Malignant Peritoneal Mesothelioma Undergoing Surgical Debulking and Intraperitoneal ChemotherapyJournal of Clinical Oncology, 2003
- Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesotheliomaJournal of Surgical Oncology, 1999
- Diffuse malignant peritoneal mesothelioma in a 13-year-old girlAmerican Journal of Surgical Pathology, 1985